Kenya review clears malaria vaccine after 1,623 reported adverse events
Health and Wellness
Kenya review clears malaria vaccine after 1,623 reported adverse events
A total of 1,623 adverse events were recorded between 2019 and 2023 during the pilot phase of the RTS,S malaria vaccine. These cases were carefully reviewed by the Pharmacy and Poisons Board and the National Vaccines and Immunization Programme, working alongside the Kenya Medical Research Institute.
By Maureen Kinyanjui